Featured News

A new article discusses the lack of research dedicated to discontinuing psychiatric drugs and reviews existing strategies.

The article suggests that research challenging the evidence for ADHD drugs does not lead to changes without public campaigns.

Adverse physiological symptoms of antidepressant withdrawal are regularly mistaken to be other problems to the detriment of the patient.

After 15 years, the founder of SurvivingAntidepressants.org, Adele Framer, shares what she has learned about the science of withdrawing from psychiatric drugs.

A new study published in JAMA Psychiatry connects antipsychotics with damage to the brain in multiple areas.

MIA’s Ayurdhi Dhar interviews Sunil Bhatia about decolonizing psychology, confronting the field’s racist past, colonial foundations, and neoliberal present.

The alternative treatment model of Soteria helps individuals suffering from schizophrenia without relying on medication or coercion.

A new study suggests that taking antidepressants impairs empathy, while the experience of depression itself does not.

An analysis of FDA adverse event reports related to esketamine shows the potential for negative effects such as suicidal and self-injurious ideation.

Bias and financial conflicts in antidepressant trials “contribute to systematic underestimation of risk in the published literature.”

Protracted Withdrawal Syndrome characterized by long-term adverse experiences after coming off of antidepressants.

A new study has found a strong association between antipsychotic drugs and higher rates of severe cases of COVID-19.

Researchers studied whether antipsychotics could prevent transition to full psychosis and found that the drugs worsened outcomes.

A large study of the population in Taiwan reveals that long-term use of benzodiazepine drugs, commonly prescribed for anxiety, significantly increases the risk for brain, colorectal, and lung cancers. The research, published open-access in the journal Medicine, also identifies the types of benzodiazepines that carry the greatest cancer risk.

New study finds that people who felt they were coerced into being hospitalized were more likely to attempt suicide later.

A new study, published in the JAMA Psychiatry, investigates the effect of stimulant ‘ADHD’ drugs on the brains of children and young adults. The...

Researchers review a new synthesis of the existing evidence and conclude that the harms of antidepressants outweigh any benefits.

Qualitative study finds that both internal resources and systemic factors play a role in antipsychotic discontinuation outcomes.

Patient advocates join with researchers and service users to present first-hand experiences of antidepressant withdrawal.

In the first systematic review of withdrawal problems that patients experience when trying to get off SSRI antidepressant medications, researchers found that withdrawing from SSRIs was comparable to trying to quit addictive benzodiazepines.

When it comes to ADHD, some researchers suggest that medical textbooks provide inaccurate and misleading information.

An article in JAMA Psychiatry advises very slow tapering for best results when discontinuing antipsychotic drugs.

Once an appropriate statistical method was used, the study findings were “no longer valid,” according to the editors of JAMA and JAMA Psychiatry.

New research finds that antidepressants are not effective for bipolar disorder and can worsen symptoms of mania.

Sinéad O'Connor discusses mental health issues with TIME magazine this week, singling out the media's tendency to diagnose "without qualification," and adding that "mental health...